Absolutely, I often wonder the same.
It’s certainly not the price action that’s keeping people from posting as anyone can see it has a spectacular chart.
It’s successfully going into new territory to treat Cancer and Idiopathic Pulmonary Fibrosis and it’s been awarded two FDA approvals.
It’s peers are in the 400m $us market cap .... AMP945 is proving to be more successful than its competitors.
I see this as one hell of an opportunity ...
.
Ann: Amplia Initiates Multiple Dose Study of AMP945, page-5
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
0.004(6.35%) |
Mkt cap ! $18.19M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 6.7¢ | 6.4¢ | $25.83K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36132 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.7¢ | 53629 | 1 |
View Market Depth
| Last trade - 15.46pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.6¢ |
Change
0.004 ( 1.54 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.6¢ | 6.3¢ | 57069 | ||
| Last updated 15.32pm 30/05/2024 ? | |||||
| ATX (ASX) Chart |